Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.33 - $7.45 $319,463 - $549,653
-73,779 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$5.84 - $13.61 $100,424 - $234,037
-17,196 Reduced 18.9%
73,779 $431,000
Q4 2021

Feb 14, 2022

SELL
$12.52 - $19.02 $739,043 - $1.12 Million
-59,029 Reduced 39.35%
90,975 $1.18 Million
Q3 2021

Nov 15, 2021

SELL
$10.47 - $20.87 $1.14 Million - $2.27 Million
-108,770 Reduced 42.03%
150,004 $2.05 Million
Q2 2021

Aug 16, 2021

SELL
$13.9 - $22.58 $821,517 - $1.33 Million
-59,102 Reduced 18.59%
258,774 $5.53 Million
Q1 2021

May 17, 2021

BUY
$15.41 - $30.42 $4.9 Million - $9.67 Million
317,876 New
317,876 $6.12 Million

Others Institutions Holding DRIO

About DarioHealth Corp.


  • Ticker DRIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 23,295,000
  • Market Cap $17.2M
  • Description
  • DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...
More about DRIO
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.